Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation

Phillip M. Pierorazio, Trinity J. Bivalacqua, Arthur L. Burnett

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation'. Together they form a unique fingerprint.

Medicine & Life Sciences